Physician profile
Roger Fan
NPI 1508928128
$8,457.57
in general payments reported to CMS, 2019-2025
19 companies · $804 in 2025
The $804 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,538 · 2020: $1,331 · 2021: $948 · 2022: $575 · 2023: $2,325 · 2024: $938 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,816 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,815.92 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,917.27 | 2019-2024 | Emblem Mri S-Icd, Acuity Steerable, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $1,625.28 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra, Cobalt Dr Mri Surescan |
| Biotronik INC. | $672.28 | 2023-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Solia |
| Abbott Laboratories | $265.87 | 2019-2025 | Aveir |
| Medtronic Vascular, INC. | $213.28 | 2019 | |
| Philips North America LLC | $189.18 | 2020-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und |
| Atricure, INC. | $136.30 | 2023-2025 | Synergy Ablation System |
| Biosense Webster, INC. | $120.96 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.39 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $48.07 | 2019 | |
| W. L. Gore & Associates, INC. | $43.93 | 2024-2025 | Gore Cardioform Septal Occluder |
| Sanofi-Aventis U.S. LLC | $27.10 | 2023 | |
| Cardiva Medical, INC. | $25.91 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Pfizer INC. | $24.14 | 2024 | |
| Novartis Pharmaceuticals Corporation | $23.20 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braemar Manufacturing, LLC | $22.28 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $18.99 | 2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $17.85 | 2019 | |
| Elutia, INC. | $7.29 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Fan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.